title: Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women.
authors.affiliation: Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. BWWALSH@BICS.BWH.HARVARD.EDU
authors.forename: B W
authors.initials: BW
authors.lastname: Walsh
authors.forename: D A
authors.initials: DA
authors.lastname: Cox
authors.forename: A
authors.initials: A
authors.lastname: Sashegyi
authors.forename: R A
authors.initials: RA
authors.lastname: Dean
authors.forename: R P
authors.initials: RP
authors.lastname: Tracy
authors.forename: P W
authors.initials: PW
authors.lastname: Anderson
mesh_terms: D000704:Analysis of Variance; D002097:C-Reactive Protein / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology*; D004311:Double-Blind Method; D004797:Enzyme-Linked Immunosorbent Assay; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D008875:Middle Aged; D010024:Osteoporosis / Q000097:blood / Q000188:drug therapy*; D017698:Postmenopause; D011446:Prospective Studies; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use*; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D004965:Estrogen Antagonists; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D020849:Raloxifene Hydrochloride; D002097:C-Reactive Protein